CY1847A - Anti-HIV activity of BV-3608 - Google Patents

Anti-HIV activity of BV-3608

Info

Publication number
CY1847A
CY1847A CY184796A CY184796A CY1847A CY 1847 A CY1847 A CY 1847A CY 184796 A CY184796 A CY 184796A CY 184796 A CY184796 A CY 184796A CY 1847 A CY1847 A CY 1847A
Authority
CY
Cyprus
Prior art keywords
susceptible
hiv
aids
infection
preventing
Prior art date
Application number
CY184796A
Other languages
English (en)
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of CY1847A publication Critical patent/CY1847A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/24—Condensed ring systems having three or more rings
    • C07H15/244—Anthraquinone radicals, e.g. sennosides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CY184796A 1988-07-01 1996-03-08 Anti-HIV activity of BV-3608 CY1847A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US21422688A 1988-07-01 1988-07-01

Publications (1)

Publication Number Publication Date
CY1847A true CY1847A (en) 1996-03-08

Family

ID=22798273

Family Applications (1)

Application Number Title Priority Date Filing Date
CY184796A CY1847A (en) 1988-07-01 1996-03-08 Anti-HIV activity of BV-3608

Country Status (12)

Country Link
EP (1) EP0351625B1 (xx)
JP (1) JP2802336B2 (xx)
KR (1) KR0131323B1 (xx)
AT (1) ATE87827T1 (xx)
CA (1) CA1335078C (xx)
CY (1) CY1847A (xx)
DE (1) DE68905875T2 (xx)
ES (1) ES2054935T3 (xx)
GR (1) GR3007580T3 (xx)
HK (1) HK110095A (xx)
IL (1) IL90783A (xx)
ZA (1) ZA894984B (xx)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5338728A (en) * 1992-08-14 1994-08-16 Bristol-Myers Squibb Pradimicin compounds

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4870165A (en) * 1987-02-02 1989-09-26 Bristol-Myers Company Antifungal antibiotics

Also Published As

Publication number Publication date
JP2802336B2 (ja) 1998-09-24
ZA894984B (en) 1990-03-28
ES2054935T3 (es) 1994-08-16
DE68905875T2 (de) 1993-07-15
DE68905875D1 (de) 1993-05-13
EP0351625B1 (en) 1993-04-07
JPH0248530A (ja) 1990-02-19
KR900001374A (ko) 1990-02-27
EP0351625A1 (en) 1990-01-24
HK110095A (en) 1995-07-14
CA1335078C (en) 1995-04-04
ATE87827T1 (de) 1993-04-15
IL90783A0 (en) 1990-01-18
IL90783A (en) 1994-01-25
GR3007580T3 (xx) 1993-08-31
KR0131323B1 (ko) 1998-04-17

Similar Documents

Publication Publication Date Title
CA2072573A1 (en) Treatment of human retroviral infections with 2',3'-dideoxyinosine
DK92788A (da) Anvendelse af 3'-deoxy-3'-flourguanosider til fremstilling af laegemidler mod retrovira
EP0403251A3 (en) Monokine activity interference
DE3780016D1 (de) Pharmazeutisches praeparat mit 3'-desoxythymidin-2'-en(3'-desoxy-2',3'-didehydrothymidin) zur behandlung von patienten mit retroviralen infektionen.
AU2930889A (en) Pharmaceutical preparation for treating immunodeficiency conditions
AU8448091A (en) Novel polypeptide and anti-hiv drug prepared therefrom
AU1226288A (en) Processes for the preparation of medicinal compositions, compositions obtained by these processes and use thereof for the preparation of medicines against viral hepatitis b and acquired immunodeficiency syndrome
EP0323157A3 (en) Antiviral compounds and methods
WO1990013281A3 (en) Method of suppressing hiv infection
CY1847A (en) Anti-HIV activity of BV-3608
AU1308188A (en) Methods of treating acquired immune deficiency syndrome (AIDS) caused by human immunodeficiency virus (HIV)
EP0311108A3 (en) Anti-hiv active 3'-azido-2,6-diaminopurine-2',3'-dideoxyriboside
EP0255242A3 (en) Oncornavirus vaccines
EP0316592A3 (en) 3'-fluoro-2',3'-dideoxyuridine, and its therapeutic application
DK135588D0 (da) Inaktivering af hiv i proteinholdige oploesninger ved hjaelp af phenoler
AU3335689A (en) Recombinant gag precursor of hiv, product, process, and use as aids vaccine
JPS6419023A (en) Heat treatment of fibrinogen and fibrinogen preparation
ZA896230B (en) Pharmaceutical composition for inhibiting infection with virus causative of acquired human immunodefeciency syndrome
UA6149A1 (uk) 2-(2'7'-діацетоксіфлуореніліден-9'-гідразоно)-5-(п-нітробензіліден)-тіазолідон-4,що виявляє противірусну дію щодо віруса грипу а та а-2, а також віруса осповакцини
JPS6471815A (en) Antiviral composition containing 5-amino-2- (4-methylpiperidine-1-yl)phenyl-4- chlorophenylmethanone
SU1797350A1 (ru) Способ обнаружения вируса иммунодефицита человека
DE3773322D1 (de) Pharmazeutische zubereitungen mit heilender aktivitaet.
UA7930A1 (uk) 2-(2,7-діацетоксіфлуорениліден-9-гідразоно)-5-фурфурилідентіазолідон-4, що виявляє противірусну дію відносно віруса венесуельського енцефаліту коней та віруса грипа типу а та а-2
UA6146A1 (uk) 1,1-біс-[2-(2,7-діацетоксифлуорениліден-9-гідразоно)тиазолідон-4-іл-5]-о-нітрофенилметан, що виявляє антивірусну дію відносно рнк- та днк- вмістних вірусів